VANCOUVER, British Columbia & LONDON, March 22, 2023--AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease
VANCOUVER, British Columbia, March 14, 2023--AbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023
Key Insights Given the large stake in the stock by institutions, AbCellera Biologics' stock price might be vulnerable...